Galectin Therapeutics Inc. (GALT) Social Stream
GALECTIN THERAPEUTICS INC (GALT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering GALECTIN THERAPEUTICS INC.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 14, 2023
The Trend in the Analyst Price Target
GALT's average price target has moved up $4.5 over the prior 42 months.
GALT reports an average of 519.43% for its upside potential over the past 33 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
GALT Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
GALT's average broker recommendation rating improved by 0 over the prior 15 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for GALT as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, GALECTIN THERAPEUTICS INC's number of analysts covering the stock is higher than nearly none of them.
- In the context of all US stocks, GALECTIN THERAPEUTICS INC's variance in analysts' estimates is lower than just about 100% of them.
- GALT has a greater upside potential (average analyst target price relative to current price) than 158.34% of stocks in the small market cap category.
- GALT has a higher average analyst price target than 44.62% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to GALECTIN THERAPEUTICS INC are ONTX, LUMO, and ADXS.
Make investment decisions regarding GALT using the data that counts. Try POWR Ratings for free.